Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.09284 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.63805 | 72 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.81557 | 74 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.31049 | 77 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.89878 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.85416 | 75 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.8249 | 75 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.80787 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.82089 | 74 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.96464 | 75 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.17926 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.9389 | 75 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.86185 | 74 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.09161 | 76 |